Blues Plans Can Use Various Tactics to Mitigate Generic Drug Price Inflation, Published in The AIS Report on Blue Cross Blue Shield Plans, V14, Number 7 July 2015 Randy Vogenberg, Ph.D., Partner, Access Market Intelligence notes that the FDA has cited “quality and manufacturing issues” as “a major reason for drug shortages. Most […]
Always Be a Step Ahead
Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.
Subscribe to AMI's Insights Newsletter Today.